chrysophanic acid has been researched along with Cardiomyopathies, Primary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Hong, H; Lu, J; Wang, J; Ye, J; Yu, Y; Yuan, J; Zhang, Y | 1 |
1 other study(ies) available for chrysophanic acid and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Topics: Animals; Animals, Newborn; Anthraquinones; Cardiomegaly; Cardiomyopathies; Isoproterenol; Janus Kinase 2; Male; Myocytes, Cardiac; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor | 2019 |